|
|||||||||||||||||||||||||||||||||
GUJARAT THEMIS BIOSYN LTD. has reported financial results for the period ended June 30, 2020. Financial Results (Q1 FY 2020-21) – QoQ Comparison The company has reported total income of Rs.16.52 crores during the period ended June 30, 2020 as compared to Rs.26.63 crores during the period ended March 31, 2020. The company has posted net profit / (loss) of Rs.5.57 crores for the period ended June 30, 2020 as against net profit / (loss) of Rs.10.95 crores for the period ended March 31, 2020. The company has reported EPS of Rs.3.84 for the period ended June 30, 2020 as compared to Rs.7.54 for the period ended March 31, 2020.
Financial Results (Q1 FY 2020-21) – YoY Comparison The company has reported total income of Rs.16.52 crores during the period ended June 30, 2020 as compared to Rs.12.40 crores during the period ended June 30, 2019. The company has posted net profit / (loss) of Rs.5.57 crores for the period ended June 30, 2020 as against net profit / (loss) of Rs.1.41 crores for the period ended June 30, 2019. The company has reported EPS of Rs.3.84 for the period ended June 30, 2020 as compared to Rs.0.97 for the period ended June 30, 2019.
Shares of GUJARAT THEMIS BIOSYN LTD. was last trading in BSE at Rs.211.15 as compared to the previous close of Rs. 205.25. The total number of shares traded during the day was 34700 in over 434 trades. The stock hit an intraday high of Rs. 214 and intraday low of 200.25. The net turnover during the day was Rs. 7237074. |
Average Rating